New LaunchJul 9, 2026, 04:01 PM
Tilray Medical Launches First Medical Cannabis Product in Panama
AI Summary
Tilray Medical, a division of Tilray Brands, Inc., announced the commercial launch of its first medical cannabis product, Tilray Oral Solution CBD100, in Panama. This marks a significant milestone in the company's global expansion efforts, providing patients with access to pharmaceutical-grade cannabinoid medicines. The product, manufactured in EU-GMP certified facilities in Portugal, will be distributed through Farmacias Arrocha under medical prescription, supporting Panama's evolving medical cannabis framework.
Key Highlights
- Tilray Medical launched its first medical cannabis product, Tilray Oral Solution CBD100, in Panama.
- The product will be distributed through Farmacias Arrocha, a leading pharmacy network in Panama.
- Product manufactured in EU-GMP certified facilities in Portugal.
- Launch is a joint venture with Solana Life Group S. de R.L.
- Supports Panama's emerging medical cannabis framework under Law 242 of 2021 and Resolution No. 0406 of May 12, 2026.
- Tilray Medical serves patients across more than 20 countries globally.
- Panama launch represents another step in Tilray Medical's broader strategy to expand access across Latin America.
Price Impact
More from TLRY